The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: "Crafting" a Microenvironment That Matters

Lucia Catani1, Michele Cavo1, Francesca Palandri2

  • 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, Institute of Hematology "Seràgnoli", University of Bologna, 40138 Bologna, Italy.

Cells
|September 28, 2021
PubMed

Insights

Extracellular vesicles (EVs) play a key role in Myeloproliferative Neoplasms (MPN) pathogenesis by mediating cell communication. Research highlights EVs

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Myeloproliferative Neoplasms (MPN) are clonal hematopoietic stem cell disorders (Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis) driven by mutations in JAK2, CALR, or MPL.
  • MPN are associated with chronic inflammation and increased risks of thrombosis, disease progression, secondary cancers, and acute leukemia.
  • Extracellular vesicles (EVs) are key mediators of intercellular communication, transferring bioactive molecules like nucleic acids and proteins.

Purpose of the Study:

  • To review the current understanding of Extracellular Vesicles (EVs) involvement in Myeloproliferative Neoplasms (MPN) pathogenesis.
  • To explore the potential of EVs as diagnostic and prognostic biomarkers in MPN.

Main Methods:

  • Literature review of recent findings on EVs in MPN.
  • Analysis of EV-mediated cross-talk mechanisms in cancer.
  • Discussion of EV roles in regulating the tumor microenvironment.

Main Results:

  • EVs are implicated in orchestrating the tumor microenvironment in MPN.
  • EVs influence angiogenesis, coagulation, immune escape, and drug resistance in MPN.
  • EVs facilitate communication between MPN cells and their surroundings.

Conclusions:

  • EVs are significantly involved in the pathogenesis of Myeloproliferative Neoplasms.
  • EVs hold promise as potential biomarkers for diagnosing and predicting outcomes in MPN patients.
  • Further research into EV function could lead to novel therapeutic strategies for MPN.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K